Stay updated with breaking news from Nasdaq Bcda. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioCardia (NASDAQ:BCDA – Get Rating) had its price objective dropped by equities researchers at Maxim Group to $4.00 in a note issued to investors on Thursday, Stock Target Advisor reports. Maxim Group’s target price points to a potential upside of 151.57% from the stock’s previous close. Other analysts have also issued research reports about the […]
Equities analysts predict that BioCardia, Inc. (NASDAQ:BCDA – Get Rating) will announce sales of $190,000.00 for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for BioCardia’s earnings, with the lowest sales estimate coming in at $130,000.00 and the highest estimate coming in at $250,000.00. BioCardia posted sales of $50,000.00 during the […]
Wall Street analysts forecast that BioCardia, Inc. (NASDAQ:BCDA – Get Rating) will report earnings per share of ($0.22) for the current quarter, according to Zacks. Two analysts have made estimates for BioCardia’s earnings. The highest EPS estimate is ($0.16) and the lowest is ($0.33). BioCardia reported earnings per share of ($0.18) in the same quarter […]
Analysts predict that BioCardia, Inc. (NASDAQ:BCDA – Get Rating) will report earnings of ($0.22) per share for the current fiscal quarter, Zacks reports. Two analysts have made estimates for BioCardia’s earnings, with estimates ranging from ($0.33) to ($0.16). BioCardia posted earnings per share of ($0.18) during the same quarter last year, which indicates a negative […]
BioCardia (NASDAQ:BCDA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. According to Zacks, “BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company’s product candidate consists of CardiAMP(TM), […]